Bicycle Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCYC and other ETFs, options, and stocks.

About BCYC

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in developing a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. The firm utilizes its novel and proprietary phage display screening platform to identify bicycles. 

CEO
Kevin Lee
CEOKevin Lee
Employees
119
Employees119
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
2009
Founded2009
Employees
119
Employees119

BCYC Key Statistics

Market cap
692.34M
Market cap692.34M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
200.71K
Average volume200.71K
High today
$24.39
High today$24.39
Low today
$23.19
Low today$23.19
Open price
$23.76
Open price$23.76
Volume
166.18K
Volume166.18K
52 Week high
$62.08
52 Week high$62.08
52 Week low
$12.08
52 Week low$12.08

Analyst ratings

86%

of 14 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

BCYC Earnings

-$0.93
-$0.62
-$0.31
-$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.